Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)

SIMPLE SUMMARY: The kinetics of SARS-CoV-2 spike-protein antibodies and the cellular immune landscape following vaccination in patients with hematologic neoplasms are poorly understood. The aim of our prospective and longitudinal study, which included 398 adults, was to compare day 35 and day 120 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Jotschke, Sabrina, Schulze, Susann, Jaekel, Nadja, Ludwig-Kraus, Beatrice, Engelmann, Robby, Kraus, Frank Bernhard, Zahn, Christina, Nedlitz, Nicole, Prange-Krex, Gabriele, Mohm, Johannes, Peuser, Bettina, Schwarz, Maik, Spohn, Claudia, Behlendorf, Timo, Binder, Mascha, Junghanss, Christian, Böttcher, Sebastian, Al-Ali, Haifa Kathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946280/
https://www.ncbi.nlm.nih.gov/pubmed/35326695
http://dx.doi.org/10.3390/cancers14061544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946280/
https://www.ncbi.nlm.nih.gov/pubmed/35326695
http://dx.doi.org/10.3390/cancers14061544

Ejemplares similares